Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Donidalorsen (IONIS-PKK-LRx) Administered Subcutaneously to Healthy Volunteers
Clinical trial NCT03263507 · COMPLETED
Trial details
- NCT number
- NCT03263507
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-28
- Primary completion
- 2018-10-09
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.